A
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
FL
Recent Filings
- SC 13G/A162.0 KBACCENTIA BIOPHARMACEUTICALS INCAug 10, 2:15 PM ET·0001457716-15-000025
- SC 13G33.4 KBACCENTIA BIOPHARMACEUTICALS INCFeb 9, 4:34 PM ET·0001193125-15-039232
- 45.6 KBACCENTIA BIOPHARMACEUTICALS INCNov 12, 5:08 PM ET·0001214659-13-006340
- 8-K44.8 KBACCENTIA BIOPHARMACEUTICALS INCJul 15, 4:40 PM ET·0001214659-13-003905
- 8-K27.6 KBACCENTIA BIOPHARMACEUTICALS INCMar 7, 4:56 PM ET·0001214659-13-001282
- 8-K27.7 KBACCENTIA BIOPHARMACEUTICALS INCFeb 22, 4:24 PM ET·0001214659-13-000986
- 10-Q1.2 MBACCENTIA BIOPHARMACEUTICALS INCFeb 14, 5:22 PM ET·0001214659-13-000877
- 10-K13.5 MBACCENTIA BIOPHARMACEUTICALS INCDec 26, 4:35 PM ET·0001193125-12-514944
- 8-K13.5 KBACCENTIA BIOPHARMACEUTICALS INCNov 23, 4:35 PM ET·0001193125-12-479724
- 45.4 KBACCENTIA BIOPHARMACEUTICALS INCOct 26, 4:56 PM ET·0001181431-12-055667
Insiders
10- Calder Douglas WVP Strategic Plan/Cap Markets
- CHAPMAN CHRISTOPHER CDirector
- DUBINSKY JOHN PDirector
- DUFFEY SAMUEL SPRESIDENT AND GENERAL COUNSEL
- Hasara Garrison J.Acting Chief Financial Officer
- HOPKINS CAPITAL GROUP LLC10% Owner
- KING EDMUNDDirector
- ODONNELL FRANCIS E JRDirector, CHAIRMAN & CEO
- Pearce Alan MDirector, Chief Financial Officer
- Poole WilliamDirector
Tickers
No tickers on record
Addresses
business
324 SOUTH HYDE PARK AVE SUITE 350
TAMPA, FL, 33606
mailing
324 SOUTH HYDE PARK AVE SUITE 350
TAMPA, FL, 33606